My relative is a prostate cancer patient who has undergone surgery and his current PSA level is 14.3. Since his prescribed quarterly Lupride injection is currently unavailable, what alternative medicine would you suggest?

A PSA level of 14.3 post-surgery indicates active disease, making continuous hormone therapy crucial. Since Lupride (Leuprolide) is unavailable, there are excellent direct alternatives. Please consult your relative's oncologist immediately to switch to another 3-monthly GnRH agonist, such as Zoladex (Goserelin) 10.8 mg or Decapeptyl/Pamorelin (Triptorelin) 11.25 mg. Alternatively, another brand of Leuprolide, like Eligard, can be used. Do not delay this transition, as maintaining testosterone suppression is vital to control the cancer's progression.